Literature DB >> 17964237

Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study.

J Jeffrey Carr1, Thomas C Register, Fang-Chi Hsu, Kurt Lohman, Leon Lenchik, Donald W Bowden, Carl D Langefeld, Jianzhou Xu, Stephen S Rich, Lynne E Wagenknecht, Barry I Freedman.   

Abstract

The purpose of the present study was to determine the relationships between atherosclerotic calcified plaque (CP) and bone mineral density (BMD) in subjects with type 2 diabetes mellitus (DM2). CP in the coronary arteries, carotid bifurcation, and abdominal aorta was measured using computed tomography (CT) in 1023 diabetic subjects from 453 families. Trabecular volumetric BMD in thoracic (T-vBMD) and lumbar (L-vBMD) spine was measured with quantitative CT (QCT), while areal BMD (aBMD) in the lumbar spine and hip was measured by dual X-ray absorptiometry (DXA). Correlation coefficients were computed to assess the magnitude of associations and generalized estimating equations (GEE1) were used to make statistical inferences while accounting for familial correlation. Subjects were 53.8% female, 85% European American (EA) and 15% African American (AA). After adjustment for age, significant inverse associations between CP and vBMD persisted in EA men (correlations between -0.11 and -0.16, all p<0.05 with the exception of carotid CP vs. T-vBMD, p=0.076) and in AA women, excluding aortic CP (correlations between -0.16 and -0.25, all p<0.05). Estrogen use in AA but not EA women was consistently associated with an inverse relation between CP and vBMD. Significant inverse relationships between CP and vBMD were observed in EA men and AA women with DM2 after adjusting for age and other covariates. QCT determined vBMD was more strongly related to CP than aBMD by DXA. The relation between CP and BMD in diabetes is influenced by age, sex, and ethnicity, with further effect modification by hormone replacement therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964237      PMCID: PMC2239236          DOI: 10.1016/j.bone.2007.08.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  39 in total

Review 1.  Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.

Authors:  Pamela Ouyang; Erin D Michos; Richard H Karas
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

2.  Usefulness of bone mineral density to predict significant coronary artery disease.

Authors:  Pamela A Marcovitz; Hillary H Tran; Barry A Franklin; William W O'Neill; Michael Yerkey; Judith Boura; Michael Kleerekoper; Christine Z Dickinson
Journal:  Am J Cardiol       Date:  2005-08-22       Impact factor: 2.778

3.  Stimulation of bone formation in vitro and in rodents by statins.

Authors:  G Mundy; R Garrett; S Harris; J Chan; D Chen; G Rossini; B Boyce; M Zhao; G Gutierrez
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

4.  Ethnic differences of the presence and severity of coronary atherosclerosis.

Authors:  Matthew J Budoff; Khurram Nasir; Songshou Mao; Philip H Tseng; Alex Chau; Sandy T Liu; Ferdinand Flores; Roger S Blumenthal
Journal:  Atherosclerosis       Date:  2005-10-21       Impact factor: 5.162

5.  Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS.

Authors:  B A Young; K Rudser; B Kestenbaum; S L Seliger; D Andress; E J Boyko
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

6.  Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip.

Authors:  Y Z Bagger; L B Tankó; P Alexandersen; G Qin; C Christiansen
Journal:  J Intern Med       Date:  2006-06       Impact factor: 8.989

7.  Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia.

Authors:  Jose Ness; Wilbert S Aronow
Journal:  Am J Cardiol       Date:  2006-03-24       Impact factor: 2.778

8.  The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study.

Authors:  B I Freedman; F C Hsu; C D Langefeld; S S Rich; D M Herrington; J J Carr; J Xu; D W Bowden; L E Wagenknecht
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

9.  Relationship between osteoporosis and cardiovascular disease in postmenopausal women.

Authors:  László B Tankó; Claus Christiansen; David A Cox; Mary Jane Geiger; Michelle A McNabb; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2005-07-18       Impact factor: 6.741

10.  Estrogen therapy and coronary-artery calcification.

Authors:  Joann E Manson; Matthew A Allison; Jacques E Rossouw; J Jeffrey Carr; Robert D Langer; Judith Hsia; Lewis H Kuller; Barbara B Cochrane; Julie R Hunt; Shari E Ludlam; Mary B Pettinger; Margery Gass; Karen L Margolis; Lauren Nathan; Judith K Ockene; Ross L Prentice; John Robbins; Marcia L Stefanick
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

View more
  32 in total

1.  The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study.

Authors:  Christina E Hugenschmidt; Fang-Chi Hsu; Satoru Hayasaka; J Jeffrey Carr; Barry I Freedman; David L Nyenhuis; Jeff D Williamson; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2013-05-07       Impact factor: 2.852

Review 2.  Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Authors:  János Nemcsik; István Kiss; András Tislér
Journal:  World J Nephrol       Date:  2012-02-06

3.  Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.

Authors:  Thomas C Register; Keith A Hruska; Jasmin Divers; Donald W Bowden; Nicholette D Palmer; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Dennis J Dietzen; Carl D Langefeld; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

4.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

5.  Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Authors:  D Liu; L Chen; S Dong; Z Peng; H Yang; Y Chen; L Li; H Zhou; R Zhou
Journal:  Osteoporos Int       Date:  2019-06-10       Impact factor: 4.507

6.  Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus.

Authors:  Jasmin Divers; Nicholette D Palmer; Lingyi Lu; Thomas C Register; J Jeffrey Carr; Pamela J Hicks; R Caresse Hightower; S Carrie Smith; Jianzhao Xu; Amanda J Cox; Keith A Hruska; Donald W Bowden; Cora E Lewis; Gerardo Heiss; Michael A Province; Ingrid B Borecki; Kathleen F Kerr; Y-D Ida Chen; Walter Palmas; Jerome I Rotter; Christina L Wassel; Alain G Bertoni; David M Herrington; Lynne E Wagenknecht; Carl D Langefeld; Barry I Freedman
Journal:  Circ Cardiovasc Genet       Date:  2012-12-11

7.  Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?

Authors:  Diana Moldovan; Ioan Moldovan; Crina Rusu; Simona Racasan; Ioan M Patiu; Adrian Brumboiu; Cosmina Bondor; Liliana Parvu; Ina Kacso; Remus Orasan; Mirela Gherman-Caprioara
Journal:  Int Urol Nephrol       Date:  2010-09-23       Impact factor: 2.370

8.  Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study.

Authors:  Thomas C Register; Jasmin Divers; Donald W Bowden; J Jeffrey Carr; Leon Lenchik; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Keith A Hruska; Carl D Langefeld; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

9.  Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.

Authors:  Jack M Heath; Yong Sun; Kaiyu Yuan; Wayne E Bradley; Silvio Litovsky; Louis J Dell'Italia; John C Chatham; Hui Wu; Yabing Chen
Journal:  Circ Res       Date:  2014-02-13       Impact factor: 17.367

10.  Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study.

Authors:  Barry I Freedman; Donald W Bowden; Julie T Ziegler; Carl D Langefeld; Allison B Lehtinen; Megan E Rudock; Leon Lenchik; Keith A Hruska; Thomas C Register; J Jeffrey Carr
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.